NovoCure NVCR
NASDAQ NVCR
$17.76 -0.44 (-2.42%)
As of: Aug 20, 2026 · 3:59 PM EDT

NovoCure (NVCR) Amortizatization of Intangibles (2014 - 2026)

NovoCure (NVCR) posted Amortizatization of Intangibles of -$2.6 million for Q2 2026, up 0.92% sequentially from -$2.6 million in Q1 2026, and up 59.86% YoY from -$1.6 million in Q2 2025.

NovoCure (NVCR) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

NovoCure has reported Amortizatization of Intangibles for 13 years, with the latest figure at -$2.6 million in Q2 2026.

  • Quarterly Amortizatization of Intangibles rose 59.86% year-over-year to -$2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$15.4 million (up 42.1% YoY) and the FY2025 annual result came in at -$23.3 million, up 9.29% from the prior year.
  • Amortizatization of Intangibles rose to -$2.6 million in Q2 2026 per NVCR's latest filing, from -$2.6 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $827000.0 in Q2 2022 and troughed at -$7.3 million in Q4 2023.
  • A 5-year average of -$4.4 million and a median of -$5.2 million in 2023 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles plunged 2984.05% in 2023, then surged 60.67% in 2026.
  • Over 5 years, Amortizatization of Intangibles stood at -$3.3 million in 2022, then slumped by 121.47% to -$7.3 million in 2023, then climbed by 8.12% to -$6.7 million in 2024, then soared by 43.85% to -$3.7 million in 2025, then soared by 30.78% to -$2.6 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$2.6 million, -$2.6 million, and -$3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 6.60 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 NovoCure 2.06 Bn 1.62 Bn 142.48 Mn -2.59 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.59 Mn
Jun 30, 2026 -2.59 Mn
Mar 31, 2026 -2.62 Mn
Mar 31, 2026 -2.62 Mn
Dec 31, 2025 -3.75 Mn
Dec 31, 2025 -3.75 Mn
Sep 30, 2025 -6.40 Mn
Sep 30, 2025 -6.40 Mn
Jun 30, 2025 -6.46 Mn
Jun 30, 2025 -6.46 Mn
Mar 31, 2025 -6.65 Mn
Mar 31, 2025 -6.65 Mn
Dec 31, 2024 -6.67 Mn
Dec 31, 2024 -6.67 Mn
Sep 30, 2024 -6.74 Mn
Sep 30, 2024 -6.74 Mn
Jun 30, 2024 -6.85 Mn
Jun 30, 2024 -6.85 Mn
Mar 31, 2024 -5.38 Mn
Mar 31, 2024 -5.38 Mn